These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37459332)

  • 21. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.
    Wang R; Guo XL; Wisman GB; Schuuring E; Wang WF; Zeng ZY; Zhu H; Wu SW
    BMC Infect Dis; 2015 Jul; 15():257. PubMed ID: 26142044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China.
    Wang L; Wang P; Ren Y; Du J; Jiang J; Jia X; Chen C; Wang Y
    PLoS One; 2016; 11(8):e0160698. PubMed ID: 27494179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-specific and genotype-specific carcinogenic human papillomavirus prevalence in a country with a high cervical cancer burden: results of a cross-sectional study in Estonia.
    Pärna K; Nygård M; Tisler A; Toompere K; Naaber P; Ratnik K; Ķīvīte Urtāne A; Zodzika J; Stankūnas M; Baltzer N; Uusküla A
    BMJ Open; 2023 Jun; 13(6):e069558. PubMed ID: 37263686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T; Dube Mandishora R; Borok M
    Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia.
    Ardhaoui M; Ennaifer E; Letaief H; Salsabil R; Lassili T; Chahed K; Bougatef S; Bahrini A; El Fehri E; Ouerhani K; Paez Jimenez A; Guizani I; Boubaker MS; Ben Alaya NB
    PLoS One; 2016; 11(6):e0157432. PubMed ID: 27299955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women.
    Zhang H; Zhang S
    Arch Gynecol Obstet; 2023 Jul; 308(1):35-41. PubMed ID: 35904609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of high-risk human papillomavirus genotypes and related risk factors among Iranian women.
    Hashemnejad M; Mirmajidi R; Rahimzadeh M; Ataei M
    J Med Life; 2022 Nov; 15(11):1340-1346. PubMed ID: 36567834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women.
    Suthipintawong C; Siriaunkgul S; Tungsinmunkong K; Pientong C; Ekalaksananan T; Karalak A; Kleebkaow P; Vinyuvat S; Triratanachat S; Khunamornpong S; Chongsuwanich T
    Asian Pac J Cancer Prev; 2011; 12(4):853-6. PubMed ID: 21790214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and Distribution of Human Papillomavirus Genotypes (1997-2019) and Their Association With Cervical Cancer and Precursor Lesions in Women From Southern Mexico.
    Alarcón-Romero LDC; Organista-Nava J; Gómez-Gómez Y; Ortiz-Ortiz J; Hernández-Sotelo D; Del Moral-Hernández O; Mendoza-Catalán MA; Antaño-Arias R; Leyva-Vázquez MA; Sales-Linares N; Antonio-Véjar V; Illades-Aguiar B
    Cancer Control; 2022; 29():10732748221103331. PubMed ID: 35608056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
    Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
    Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic diversity of human papillomavirus (HPV) as specified by the detection method, gender, and year of sampling: a retrospective cross-sectional study.
    Finan RR; Chemaitelly H; Racoubian E; Aimagambetova G; Almawi WY
    Arch Gynecol Obstet; 2023 May; 307(5):1469-1479. PubMed ID: 36624228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
    Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
    PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.
    Castellsagué X; Iftner T; Roura E; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; San Martin Rodriguez M; Serradell L; Torcel-Pagnon L; Cortes J;
    J Med Virol; 2012 Jun; 84(6):947-56. PubMed ID: 22499018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype distribution of cervical HPV among Caribbean women in a population-based study in Martinique: The DEPIPAPUFR study.
    Najioullah F; Dorival MJ; Joachim C; Dispagne C; Macni J; Abel S; Sulpicy C; Charpentier-Baltide H; Sainte-Rose D; Salomon-Frechou B; Dieye M; Véronique-Baudin J; Pré M; Marquet M; Wan-Ajouhu G; Janky E; Riethmuller D; Cesaire R;
    PLoS One; 2021; 16(10):e0257915. PubMed ID: 34618835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran.
    Ghaffari SR; Sabokbar T; Mollahajian H; Dastan J; Ramezanzadeh F; Ensani F; Yarandi F; Mousavi-Jarrahi A; Mohagheghi MA; Moradi A
    Asian Pac J Cancer Prev; 2006; 7(4):529-32. PubMed ID: 17250423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in genotype prevalence of human papillomavirus over 10-year follow-up of a cervical cancer screening cohort].
    Dong L; Hu SY; Zhang Q; Feng RM; Zhang L; Zhao XL; Ma JF; Shi SD; Zhang X; Pan QJ; Zhang WH; Qiao YL; Zhao FH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):20-25. PubMed ID: 28100371
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
    Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV genotype prevalence in Indian women with cervical disease and estimation of the potential impact of HPV vaccines on prevention of cervical cancer.
    Nagaraja M; Narendra H; Venkataramana B; Kalawat U
    Indian J Med Microbiol; 2023; 43():73-78. PubMed ID: 36241529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.